Children's Hospital is part of the UPMC family.
This Children’s Oncology Group Phase III study seeks to develop standards of therapy for various types and stages of the rare kidney tumor known as the Wilms tumor and certain precursor conditions. Researchers hope that through this research, chemotherapy treatments can be refined so as to eliminate tumor cells while preserving as much of the kidney as possible.
Subject to certain exclusion criteria, the study is open to individuals of both genders, who have been diagnosed with Wilms tumor or who have been diagnosed with diffuse hyperplastic perilobar nephrogenic rests (DHPLNR), which have a higher likelihood of developing into a Wilms tumor.
Males: Up to age 22
Females: Up to age 22
Researchers have established separate tracks depending on they type and stage of Wilms tumor or DHPLNR. Each begins with 3, 2-week cycles of chemotherapy followed by evaluation and possible surgery, followed by additional chemotherapy and possibly additional surgery. The length of participation will vary with the regimen, which may last from 18 to 43 weeks.
Duration: 18 to 43 weeks, with patients followed for up to 10 years
Children’s Oncology Group (Study AREN0534)
National Cancer Institute
Study Description at National Institutes of Health
A. Kim Ritchey, MD
For additional information, please contact:
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
Children’s Hospital of Pittsburgh of UPMC
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Visit Children's Hospital of Pittsburgh Foundation's website to: